• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

1-Alpha-hydroxy vitamin D3 in primary hyperparathyroidism.

作者信息

Boyle I T, Fogelman I, Beastall G H, Joffe S, Boyce B

出版信息

Br Med J. 1979 Mar 24;1(6166):822-3. doi: 10.1136/bmj.1.6166.822-b.

DOI:10.1136/bmj.1.6166.822-b
PMID:435823
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1598441/
Abstract
摘要

相似文献

1
1-Alpha-hydroxy vitamin D3 in primary hyperparathyroidism.原发性甲状旁腺功能亢进症中的1α-羟维生素D3
Br Med J. 1979 Mar 24;1(6166):822-3. doi: 10.1136/bmj.1.6166.822-b.
2
Effect of intravenous 1-alpha-hydroxyvitamin D3 on secondary hyperparathyroidism in chronic uremic patients on maintenance hemodialysis.静脉注射1-α-羟维生素D3对维持性血液透析慢性尿毒症患者继发性甲状旁腺功能亢进的影响。
Nephron. 1989;53(3):194-200. doi: 10.1159/000185744.
3
Value of 1-alpha-hydroxy vitamin D3 in treatment of primary hyperparathyroidism before parathyroidectomy.1-α-羟维生素D3在甲状旁腺切除术治疗原发性甲状旁腺功能亢进症之前的治疗价值。
Br Med J. 1979 Feb 17;1(6161):450-2. doi: 10.1136/bmj.1.6161.450.
4
[Evaluation of the treatment efficacy of secondary hyperparathyroidism with oral pulse doses of alphacalcidol].
Pol Arch Med Wewn. 1997 Oct;98(10):358-65.
5
Hypoparathyroidism: practice and theoretical backgrounds for 1 alpha(OH)D3 treatment.
Bone Miner. 1990 Jun;9(3):229-32. doi: 10.1016/0169-6009(90)90040-m.
6
[Hypophosphatemic vitamin D-resistant osteomalacia treated with 1 alpha- hydroxyvitamin D3 (Etalpha)].用1α-羟维生素D3（阿法骨化醇）治疗低磷性维生素D抵抗性骨软化症
Ugeskr Laeger. 1980 Apr 28;142(18):1154-5.
7
Influence of 1 alpha-hydroxy vitamin D3 (0.25 micrograms/day) and calcium carbonate on patients with chronic renal failure at the predialytic stage.
Nihon Jinzo Gakkai Shi. 1989 Jun;31(6):657-60.
8
1-alpha-Hydroxyvitamin D3 in the management of primary hyperparathyroidism with bone disease.
Calcif Tissue Res. 1977 May;22 Suppl:415. doi: 10.1007/BF02064116.
9
Double-blind trial of oral 1,25-dihydroxy vitamin D3 versus placebo in asymptomatic hyperparathyroidism in patients receiving maintenance haemodialysis.接受维持性血液透析的无症状甲状旁腺功能亢进患者口服1,25-二羟基维生素D3与安慰剂的双盲试验。
Br Med J (Clin Res Ed). 1981 Jun 13;282(6280):1919-24. doi: 10.1136/bmj.282.6280.1919.
10
Osteoid mineralization defect in primary hyperparathyroidism.
Clin Endocrinol (Oxf). 1973 Oct;2(4):377-86. doi: 10.1111/j.1365-2265.1973.tb01724.x.

本文引用的文献

1
1alpha-hydroxyvitamin D3 in primary hyperparathyroidism.
Clin Endocrinol (Oxf). 1977 Dec;7 Suppl:215s-222s. doi: 10.1111/j.1365-2265.1977.tb03384.x.
2
Vitamin D metabolism and parathyroid function in man.人类的维生素D代谢与甲状旁腺功能
Clin Sci Mol Med. 1975 May;48(5):349-65. doi: 10.1042/cs0480349.